Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 15;10(5):585.
doi: 10.3390/antibiotics10050585.

Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing Klebsiella pneumoniae Requiring Hospitalization in Spain: An Observational Cohort Study

Dawid Rozenkiewicz  1   2   3 , Erika Esteve-Palau  1   2   3 , Mar Arenas-Miras  1   2   3   4 , Santiago Grau  3   4   5 , Xavier Duran  6 , Luisa Sorlí  1   2   3   4 , María Milagro Montero  1   2   3   4 , Juan P Horcajada  1   2   3   4
Affiliations

Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing Klebsiella pneumoniae Requiring Hospitalization in Spain: An Observational Cohort Study

Dawid Rozenkiewicz et al. Antibiotics (Basel). .

Abstract

Objective: To analyze the clinical and economic impact of community-onset urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae requiring hospitalization. Methods: A retrospective cohort study that included all adults with a UTI caused by K. pneumoniae that were admitted to a tertiary care hospital in Barcelona, Spain, between 2011 and 2015. Demographic, clinical, and economic data were analyzed. Results: One hundred and seventy-three episodes of UTIs caused by K. pneumoniae were studied; 112 were non-ESBL-producing and 61 were ESBL-producing. Multivariate analysis identified ESBL production, acute confusional state associated with UTI, shock, and the time taken to obtain adequate treatment as risk factors for clinical failure during the first seven days. An economic analysis showed differences between ESBL-producing and non-ESBL-producing K. pneumoniae for the total cost of hospitalization per episode (mean EUR 6718 vs EUR 3688, respectively). Multivariate analysis of the higher costs of UTI episodes found statistically significant differences for ESBL production and the time taken to obtain adequate treatment. Conclusion: UTIs caused by ESBL-producing K. pneumoniae requiring hospitalization and the time taken to obtain adequate antimicrobial therapy are associated with worse clinical and economic outcomes.

Keywords: ESBL-producing Klebsiella pneumoniae; clinical impact; economic impact; urinary tract infection.

PubMed Disclaimer

Conflict of interest statement

J.P.H. has received honoraria for speaker activities and advisory boards from MSD, Pfizer, Angelini, Menarini. All the other authors declare no conflict of interest.

References

    1. WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed. [(accessed on 9 May 2021)]; Available online: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-....
    1. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: A clinical update. Clin. Microbiol. Rev. 2005;18:657–686. doi: 10.1128/CMR.18.4.657-686.2005. - DOI - PMC - PubMed
    1. Richelsen R., Smit J., Anru P.L., Schønheyder H.C., Nielsen H. Incidence of community-onset extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae infections: An 11-year population-based study in Denmark. Infect. Dis. 2020;52:547–556. doi: 10.1080/23744235.2020.1763452. - DOI - PubMed
    1. Podschun R., Ullmann U. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 1998;11:589–603. doi: 10.1128/CMR.11.4.589. - DOI - PMC - PubMed
    1. Cantón R., Loza E., Aznar J., Castillo F.J., Cercenado E., Fraile-Ribot P.A., Gonzalez-Romo F., Lopez-Hontangas J.L., Rodriguez-Lozano J., Suarez-Barrenechea A.I., et al. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017) Rev. Esp. Quimioter. 2019;32:145–155. - PMC - PubMed

LinkOut - more resources